Entities / Company
Candel Therapeutics.
company in Auburndale, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 32
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Candel Therapeutics stock was listed on the Nasdaq exchange on August 18, 2026.Some support1 report
-
Candel Therapeutics and Gossamer Bio, Inc. are competing in the small-cap healthcare market.Some support1 report
-
Candel Therapeutics traded on the Nasdaq stock exchange on June 30, 2026.Some support2 reports
Gone quiet
No new reports in 90+ days-
Paul Manning purchased shares of Candel Therapeutics, amid discussion of potential benefits from Trump's policies for US stocks.Speculative1 report
-
Charles Schoch, who holds an MBA and MSA from Northeastern University, served as Corporate Controller at Corbus Pharmaceuticals and was appointed CFO of Candel Therapeutics.Speculative1 report
-
Candel Therapeutics filed a registration statement with the SEC on June 24, 2025.Speculative1 report
-
Candel Therapeutics was included in Russell indexes on July 9, 2025, signaling market recognition.Speculative2 reports
-
Candel Therapeutics is advancing its immunotherapy using HSV gene constructs, with clinical trials underway under FDA agreement.Some support1 report
-
FDA granted RMAT Designation and EMA granted Orphan Designation for CAN-2409, a drug candidate from Candel Therapeutics.Some support2 reports
-
Citi's conference is held in Boston, MA.Some support3 reports1 development inside
No events began in the chosen period. Widen it, or reset.
Around Candel Therapeutics this week
News at the entities that move Candel Therapeutics most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves Candel Therapeutics
-
Boston Shared contextThe Federal Aviation Administration is managing air traffic operations at Boston Logan Airport.Moves Candel Therapeutics
-
Benzinga Mentioned togetherBenzinga reported on the recent stock price activity of SpaceX.Moves Candel Therapeutics
-
Nasdaq Shared contextApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Candel Therapeutics
Connections
The 6 strongest of 32, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
FDA formally regulates Candel Therapeutics, granting designations and overseeing clinical trials for its drug candidates.
-
Mark Sims Structural
Candel Therapeutics appointed Mark Sims as Chief Commercial Officer.
-
Boston Shared context
Candel Therapeutics is associated with Boston as a location for professional events.
-
Benzinga Mentioned together
Candel Therapeutics is covered and reported on by Benzinga and similar financial news aggregators.
-
Francesca Barone Transactional
Francesca Barone, as an insider, sold company shares of Candel Therapeutics.
-
Nasdaq Shared context
Candel Therapeutics is listed and trades on the Nasdaq stock exchange.
History
Events by the month they beganAugust 2026
2 eventsJune 2026
8 events- Candel Therapeutics traded on the Nasdaq stock exchange on June 30, 2026.
- Paul Manning purchased shares of Candel Therapeutics, amid discussion of potential benefits from Trump's policies for US stocks.
- Charles Schoch, who holds an MBA and MSA from Northeastern University, served as Corporate Controller at Corbus Pharmaceuticals and was appointed CFO of Candel Therapeutics.
- Candel Therapeutics filed a registration statement with the SEC on June 24, 2025.
- Candel Therapeutics was included in Russell indexes on July 9, 2025, signaling market recognition.
- Candel Therapeutics is advancing its immunotherapy using HSV gene constructs, with clinical trials underway under FDA agreement.
- FDA granted RMAT Designation and EMA granted Orphan Designation for CAN-2409, a drug candidate from Candel Therapeutics.
- Citi's conference is held in Boston, MA.